Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-041524
Filing Date
2018-08-02
Accepted
2018-08-02 07:01:44
Documents
27
Period of Report
2018-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv498999_6k.htm 6-K 169077
2 EXHIBIT 99.1 tv498999_ex99-1.htm EX-99.1 94720
3 GRAPHIC image_001.jpg GRAPHIC 12722
4 GRAPHIC image_002.jpg GRAPHIC 3250
  Complete submission text file 0001144204-18-041524.txt   1147516

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glmd-20180630.xml EX-101.INS 88595
6 XBRL TAXONOMY EXTENSION SCHEMA glmd-20180630.xsd EX-101.SCH 12334
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glmd-20180630_cal.xml EX-101.CAL 21702
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glmd-20180630_def.xml EX-101.DEF 93335
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glmd-20180630_lab.xml EX-101.LAB 123391
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glmd-20180630_pre.xml EX-101.PRE 102180
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 18986607
SIC: 2834 Pharmaceutical Preparations